Liver Neoplasm Malignant Primary
1 clinical trials · Condition
◉ Watch Liver Neoplasm Malignant Primary
| Record | Firm | Date |
|---|---|---|
| Lenvatinib Combined Pembrolizumab in Advanced Hepatobiliary Tumors (NCT03895970) | Peking Union Medical College Hospital | 2019-04-20 |
Track Liver Neoplasm Malignant Primary automatically
Every clearance here is in the API, with alerts when new ones post.